Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Search

Top

D & R PHARMACEUTICAL SERVICES, LLC

UEI: R9M2DKSTK3F1CAGE: 9NYN0

D & R PHARMACEUTICAL SERVICES, LLC is a federal contractor, registered under UEI R9M2DKSTK3F1 and CAGE code 9NYN0. It has been awarded $6,022,509 in federal contracts. Primary work spans Pharmacies and Drug Retailers and Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Phone+1 (555) 000-0000

Address123 Main St, City, ST 12345

Registration

UEI Code

R9M2DKSTK3F1

CAGE Code

9NYN0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationLimited Liability Company

NAICS Codes

456110Pharmacies and Drug Retailers(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

D & R Pharmaceutical Services, LLC specializes in pharmacy dispensing services for veteran healthcare systems, delivering end-to-end pharmaceutical operations including prescription fulfillment, medication management, and inventory control within VA-affiliated facilities. The contractor provides mis...

Key Performance Metrics

Awards Count

16

All time

Active

4

Currently performing

Completed

12

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Veterans Affairs$6.0M100%

Awards by NAICS

456110 - Pharmacies and Drug Retailers$3.6M59%325412 - Pharmaceutical Preparation Manufacturing$2.5M41%

Awards by Agency Over Time

Awards by Place of Performance

Compete with D & R PHARMACEUTICAL SERVICES, LLC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for D & R PHARMACEUTICAL SERVICES, LLC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in D & R PHARMACEUTICAL SERVICES, LLC's top NAICS codes and agencies

Supply of Bupivacaine Hydrochloride InjectionThis subcontract involves the supply of pharmaceutical-grade Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML (NSN: 6505001387347) to prime contractors supporting Department of Defense DLA Troop Support medical supply contracts. The agreement requires the delivery of 2,000 units within a strict five-day window, ensuring all products meet USP standards and possess a minimum shelf-life of 24 months. To maintain product integrity, the supplier must utilize climate-controlled logistics to keep the injections within a temperature range of 20 to 25 degrees Celsius. This procurement is managed under NAICS code 325412 through the Medical Supply Chain Pharm FSA.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

ARTIFICIAL TEARS SOLUT

Solicitation # SPE2DP-27-T-0204

Solicitation SPE2DP-27-T-0204 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 40 bottles of 1.4% artificial tears solution (NSN 6505009617486), each with a 15 ML capacity. The contract requires a non-extendable shelf life of 36 months and specifies delivery to the USS NITZE DDG 94. Delivery is required within 20 days after receipt of order, with an original required delivery date of October 28, 2026. The terms are FOB Destination, and both inspection and acceptance will occur at the destination. The contractor must adhere to strict packaging and marking standards, primarily Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial and sealed in suitable containers to prevent damage, with palletization following DLA requirement RP001. If the material is deemed hazardous per FED-STD-313, it must be packaged according to TQ requirement IP025 and labeled per the Hazard Communication Standard; otherwise, ASTM D3951 applies. Invoicing must be processed electronically through the Wide Area WorkFlow system. The award process includes a HUBZone price evaluation preference, and any offers utilizing additive manufacturing are ineligible for award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-27-T-0202

This solicitation, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of six units of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product is a 1% W/V Permethrin active ingredient supplied in a 2 fl oz plastic squeeze bottle and must include a comb. The item is FDA-regulated and has a total shelf life of 24 months, with a mandatory minimum of 21 months remaining upon receipt by the government. Delivery is required within five days after receipt of order (ADO) to a destination in Poland. The contract mandates strict adherence to medical and hazardous material standards, requiring marking in accordance with Medical Marking Standard No. 1 and packaging per MIL-STD-2073-1E. Suppliers must provide Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award, with a copy of the SDS accompanying each shipment. Invoicing must be processed through the Wide Area WorkFlow (WAWF) system. Key regulatory clauses include the Buy American Act, DFARS cybersecurity reporting requirements, and the prohibition of additive manufacturing processes for the provided items. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-27-T-0206

Solicitation SPE2DP-27-T-0206 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of 50 bottles of Hydrogen Peroxide Topical Solution, USP. The product is an over-the-counter topical solution for external use containing 3% stabilized hydrogen peroxide, with each unit of issue consisting of a 473 milliliter bottle. Delivery is required within 20 days of award to a destination in Washington DC. The procurement is governed by NAICS code 325412 and requires compliance with the Buy American and Balance of Payments Program for quotes exceeding the micro-purchase threshold. The contractor must adhere to strict quality and safety standards, including FDA regulations and the DLA Master List of Technical and Quality Requirements. Packaging and marking must comply with MIL-STD-2073-1E, Medical Marking Standard No. 1, and Special Packaging Instructions MPPWN00001. Because the item is classified as hazardous material, the contractor must provide a current Material Safety Data Sheet (MSDS) and ensure all labeling and shipping comply with 49 CFR, ICAO, and IMDG regulations. Inspection and acceptance will occur at the destination per FAR 52.246-2. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

SIMETHICONE TABLETS

Solicitation # SPE2DP-27-T-0207

Solicitation SPE2DP-27-T-0207 is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Simethicone Tablets, USP, 80 mg, chewable. The required product is an FDA-regulated drug provided in unit dose 100-count blister packs. Key technical specifications include a non-extendable shelf life of 36 months for Type I (Code Q) items. The contract requires delivery to the DC ARNG Med Det in Washington, DC, with a delivery window of 20 days after receipt of order and a required delivery date of November 2, 2026. The contractor must adhere to strict packaging and marking standards, specifically Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging data per MIL-STD-2073-1E. Inspection and acceptance will occur at the destination. Administrative requirements include electronic invoicing via the Wide Area WorkFlow (WAWF) system and compliance with various FAR and DFARS clauses, including the Buy American Act and cybersecurity reporting under DFARS 252.204-7012. Quotations must be submitted via the DIBBS portal by November 4, 2026, and the submission of a Safety Data Sheet is mandatory for a responsibility determination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

LORATADINE TABLETS

Solicitation # SPE2DP-27-T-0208

Solicitation SPE2DP-27-T-0208, issued by DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Loratadine 10 mg tablets (NSN 6505-01-524-9179). The requirement is for two bottles, with each bottle containing 500 tablets. The items are FDA-regulated and must be stored between 20° to 25° C and protected from excessive moisture. The product is classified as a Type I (Code Q) item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of order, with terms set as FOB Destination and performance located at Camp Pendleton, California. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers in accordance with MIL-STD-2073-1E and special packaging instructions MPPWN00001. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various federal regulations, including the Buy American Act, DFARS requirements for safeguarding covered defense information, and prohibitions on certain telecommunications equipment. Quotations are due by November 4, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

BUPIVACAINE HYDROCHLOR

Solicitation # SPE2DP-27-T-0203

Solicitation SPE2DP-27-T-0203, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is a small business set-aside for the procurement of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 ML. The requirement consists of two units under NSN 6505001387347, with a non-extendable shelf life of 24 months. The product is FDA-regulated and must be stored between 20 to 25 degrees Celsius. Delivery is required within five days of award, with an original required delivery date of October 30, 2026, shipped FOB Destination to the US Army SSA in Powidz, Poland. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical materials. Packaging must be commercial, utilizing sealed unit containers and exterior shipping containers compliant with MIL-STD-2073-1E and DLA packaging requirements for palletization. Inspection and acceptance will occur at the destination per FAR 52.246-2. Administrative requirements include the use of the Wide Area WorkFlow system for electronic invoicing and payment. The solicitation incorporates various FAR and DFARS clauses regarding hazardous material identification, cybersecurity reporting, and domestic origin preferences under the Buy American Act.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 5 hours ago

DEADLINE

ISOPROPYL RUBBING ALCO

Solicitation # SPE2DS-27-T-1126

This solicitation, issued by DLA Troop Support Medical Supply Chain MD SURG FSF under solicitation number SPE2DS-27-T-1126, is for the procurement of one bottle of 70 percent USP Isopropyl Rubbing Alcohol (NSN 6505-01-078-9605). The item must be provided in a one-gallon plastic bottle with a total shelf life of 36 months, requiring a minimum of 31 months of remaining shelf life upon receipt by the government. Delivery is designated as a vessel shipment to the USS VIRGINIA SSN 774, with a required delivery date of November 2, 2026. Inspection and acceptance will occur at the destination. The contract mandates strict adherence to hazardous materials regulations, requiring a current Material Safety Data Sheet (MSDS) to accompany each shipment and electronic submission to DLA. Packaging must comply with RP001 DLA requirements, ASTM D3951, 49 CFR, and either ICAO or IMDG standards. Labeling must follow Medical Marking Standard No. 1A. Additionally, the contractor must ensure that no mercury or mercury-containing compounds are intentionally added to the supplies. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with the Buy American and Balance of Payments Program, as well as various DFARS cybersecurity and telecommunications restrictions. All quotes must be submitted via the DLA Internet Bid Board System (DIBBS).

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 5 hours ago

DEADLINE

Atropine Autoinjector ManufacturingThis subcontract with DLA Troop Support involves the manufacturing of automatic Atropine Injection systems, specifically producing 2mg of Atropine Sulfate per 0.7mL. The scope of work includes the production of the sterile solution, integration into automatic injector devices, and the execution of rigorous sterility and bacterial endotoxin testing in accordance with USP 2.4.1 and NDA No. 212319. To fulfill the requirements, the provider must maintain FDA registration and operate within sterile manufacturing facilities. The final deliverables are sterile Atropine Autoinjectors intended for prime contractors on DLA supply contracts, with performance centered in Philadelphia.

DLA Troop Support

POSTED

about 10 hours ago

DEADLINE

in about 1 month

Cell Separation and Processing Reagent SupplierThis subcontract opportunity is for a supplier to provide chemical reagents to prime contractors supporting the Department of Veterans Affairs VISN 2. The scope of work focuses on the delivery of specialized cell separation media and processing reagents essential for the preparation phase of the tuberculosis diagnostic workflow, ensuring all materials meet specific clinical environment technical specifications. Managed by the Network Contract Office 02, the contract falls under NAICS code 325412. The place of performance is located in Buffalo, New York. Interested parties should note the posted date of October 29, 2026, with a response deadline set for November 12, 2026.

242-NETWORK Contract Office 02 (36C242)

POSTED

about 10 hours ago

DEADLINE

Laboratory Quality Control (QC) Material SupplierThis subcontract opportunity is for a Laboratory Quality Control Material Supplier to support prime contractors delivering medical laboratory supplies to the Department of Veterans Affairs VISN 2. The selected provider will be responsible for delivering validated positive and negative control reagents and standardized control samples. These materials are essential for validating the accuracy and consistency of TB assays in accordance with established clinical laboratory quality control standards. The contract is managed by the Department of Veterans Affairs Network Contract Office 02, with the place of performance located in Buffalo, New York. Interested parties should note that the response deadline is November 12, 2026, and the requirement falls under NAICS code 325412.

242-NETWORK Contract Office 02 (36C242)

POSTED

about 10 hours ago

DEADLINE

Supply of Ramipril Capsules (Multiple Dosages)

Nac Pharmaceuticals (36E797)

POSTED

about 10 hours ago

DEADLINE

Radiopharmaceutical Supply and Logistics (Lutathera/Pluvicto)

244-NETWORK Contract Office 4 (36C244)

POSTED

about 10 hours ago

DEADLINE

Atropine Auto-Injector

Solicitation # SPE2DP-27-R-ATRO

DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.

DLA Troop Support

POSTED

about 10 hours ago

DEADLINE

in about 1 month

6505--INTENT TO SOLE SOURCE Radiopharm - Lutathera & Pluvicto - Lebanon VAMC

Solicitation # 36C24427Q0045

The Department of Veterans Affairs, Network Contracting Office 4, intends to establish a firm-fixed-price contract for the procurement and delivery of name-brand Lutathera and Pluvicto radiopharmaceuticals for the Lebanon VA Medical Center. The scope of work includes the distribution, transportation, and inventory management of 8 doses of Lutathera and 48 doses of Pluvicto, both at 200mCi intravenous injection. The proposed period of performance is from January 1, 2027, to December 31, 2027. The government intends to sole source this requirement to Novartis Pharmaceuticals Corporation under the Revolutionary FAR Overhaul (RFO) for FAR 8.4 and GSAM/R 538.71, in accordance with Executive Order 14275. The contractor must be licensed by the Nuclear Regulatory Commission and comply with FDA, OSHA, and DOT regulations, including the use of lead-shielded containers and specific labeling requirements such as bar-coding for dose tracking. Deliveries must be made F.O.B. Destination to the Lebanon VA Medical Center, with routine shipments arriving at least one hour before calibration time. Preference will be given to contractors utilizing non-High Enriched Uranium sources. This notice is for planning purposes, and interested vendors must submit a one-page capability statement, including their SAM UEI number and socioeconomic category, to the Contracting Specialist by November 3, 2026, at 14:00 PM EST. The procurement falls under NAICS code 325412 with an SBA size standard of 1,300 employees.

244-NETWORK Contract Office 4 (36C244)

POSTED

about 10 hours ago

DEADLINE

6505--Ramipril Capsules RFP

Solicitation # 36E79726R0034

The VA National Acquisition Center is issuing an unrestricted Request for Proposal, solicitation 36E79726R0034, for the procurement of Ramipril capsules to support the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract will be awarded to a single responsible offeror capable of providing an uninterrupted source of supply for a base period of one year with four pre-priced one-year option periods. Distribution will be managed through the respective Pharmaceutical Prime Vendor Programs of the VA and DOD. The procurement is conducted in commercial item format according to FAR Part 12 under NAICS code 325412. The requirement covers various Ramipril capsule strengths and bottle sizes, including 1.25mg, 2.5mg, 5mg, and 10mg options in 100-count and 500-count bottles, with total estimated annual requirements ranging from 1,611 to 15,956 units per item. Critical compliance requirements include the provision of a unique NDC number and the exact label name for each drug. Additionally, the use of glass bottles is strictly prohibited. The solicitation is expected to be issued around November 16, 2026, with a tentative closing date of November 30, 2026. Amber Zavala serves as the primary point of contact for this procurement.

Nac Pharmaceuticals (36E797)

POSTED

about 10 hours ago

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970-01-012-4280)This subcontract involves the supply of electrical insulation tape, identified by NSN 5970-01-012-4280, for prime contractors working on DLA Weapons Support ASC projects. The contractor is required to provide two rolls of tape delivered FOB Origin to Evenes Airbase. All materials must strictly conform to technical specification BASIC CID A-A-59474D, Revision D, and adhere to MIL-STD-2073-1E and RP001 for packaging and MIL-STD-129 for marking. To be eligible, the supplier must hold either SAE AS9003 or ISO 9001 certification and maintain full compliance with DFARS 252.204-7012. This procurement is managed by the Department of Defense under the DLA Weapons Support ASC Supplier Oper AE and AF Div, with a response deadline set for November 5, 2026.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Sterile X-Ray Detectable Packing Gauze SupplierThis subcontract involves the supply of 640 units of sterile, medical-grade packing gauze for prime contractors supporting Department of Defense medical supply contracts. The required product is a 1-ply, soft, white Z-fold gauze measuring 3 inches by 5 yards, featuring an embedded X-ray detectable line. To ensure clinical safety and longevity, the gauze must be sterilized to medical standards to maintain a shelf life of 60 months. The contract is managed under the Medical Supply Chain MD Surg FSF and requires strict adherence to the Berry Amendment and the Buy American Act for NSN 6510-01-695-5824. Performance for this requirement is centered in San Diego, California. Interested parties must note the response deadline of November 3, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE